CUSIP: 744375205
Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,053,934
-
Share change
-
-83,348
-
Total reported value
-
$62,780,680
-
Price per share
-
$20.56
-
Number of holders
-
45
-
Value change
-
-$1,374,542
-
Number of buys
-
20
-
Number of sells
-
23
Quarterly Holders Quick Answers
What is CUSIP 744375205?
CUSIP 744375205 identifies PMD - PSYCHEMEDICS CORPORATION CMN - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2018
-
Previous quarter:
Q3 2017
Recent filing periods for CUSIP 744375205:
Institutional Holders of PSYCHEMEDICS CORPORATION CMN - COM (PMD) as of Q4 2017
As of 31 Dec 2017,
PSYCHEMEDICS CORPORATION CMN - COM (PMD) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,053,934 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, Moors & Cabot, Inc., Tieton Capital Management, LLC, CRAWFORD INVESTMENT COUNSEL INC, Vanguard Group Inc, Uniplan Investment Counsel, Inc., DIMENSIONAL FUND ADVISORS LP, BLAIR WILLIAM & CO/IL, North Star Investment Management Corp., and RBF Capital, LLC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.